Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin in cancer
Ritwika Mallik, Tahseen A Chowdhury
Diabetes Research and Clinical Practice (2018) Vol. 143, pp. 409-419
Closed Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

Obesity and cancer risk: Emerging biological mechanisms and perspectives
Konstantinos Avgerinos, Nikolaos Spyrou, Christos S. Mantzoros, et al.
Metabolism (2018) Vol. 92, pp. 121-135
Open Access | Times Cited: 1260
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Lisa M. Butler, Ylenia Perone, Jonas Dehairs, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 245-293
Open Access | Times Cited: 472
Role of Mitochondria in the Mechanism(s) of Action of Metformin
Guillaume Vial, Dominique Détaille, Bruno Guigas
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 250
The effects of metformin on autophagy
Guangli Lu, Zhen Wu, Jia Shang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111286-111286
Open Access | Times Cited: 123
Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study
Reynalda Córdova, Vivian Viallon, Emma Fontvieille, et al.
The Lancet Regional Health - Europe (2023) Vol. 35, pp. 100771-100771
Open Access | Times Cited: 113
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 98
Hypoxia-responsive PPARGC1A/BAMBI/ACSL5 axis promotes progression and resistance to lenvatinib in hepatocellular carcinoma
Qiangnu Zhang, Lingfeng Xiong, Wei Teng, et al.
Oncogene (2023) Vol. 42, Iss. 19, pp. 1509-1523
Closed Access | Times Cited: 54
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 34
Acidosis activates breast cancer ferroptosis through ZFAND5/SLC3A2 signaling axis and elicits M1 macrophage polarization
Hanchu Xiong, Yanan Zhai, Yimei Meng, et al.
Cancer Letters (2024) Vol. 587, pp. 216732-216732
Closed Access | Times Cited: 21
Glycerol 3-phosphate dehydrogenases (1 and 2) in cancer and other diseases
Sehyun Oh, Xuan Linh, Jiwoo Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 5, pp. 1066-1079
Open Access | Times Cited: 20
Examining the clinical relevance of metformin as an antioxidant intervention
Angelika Buczyńska, Iwona Sidorkiewicz, Adam Krętowski, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18
Metformin: A Dual-Role Player in Cancer Treatment and Prevention
Mariam Ahmed Galal, Mohammed Al-Rimawi, Abdurrahman Hajeer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4083-4083
Open Access | Times Cited: 17
Anticancer Activity of Metformin: A Systematic Review of the Literature
Mohamad Aljofan, Dieter Riethmacher
Future Science OA (2019) Vol. 5, Iss. 8
Open Access | Times Cited: 146
Metabolic Heterogeneity of Cancer Cells: An Interplay between HIF-1, GLUTs, and AMPK
Nurbubu T. Moldogazieva, Innokenty M. Mokhosoev, Alexander A. Terentiev
Cancers (2020) Vol. 12, Iss. 4, pp. 862-862
Open Access | Times Cited: 134
Glioblastoma Stem-Like Cells, Metabolic Strategy to Kill a Challenging Target
Delphine Garnier, Ophélie Renoult, Marie‐Clotilde Alves‐Guerra, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 131
Serine, glycine and one‑carbon metabolism in cancer (Review)
Sijing Pan, Ming Fan, Zhangnan Liu, et al.
International Journal of Oncology (2020) Vol. 58, Iss. 2, pp. 158-170
Open Access | Times Cited: 123
Targeting mitochondria in cancer: current concepts and immunotherapy approaches
Sergei Pustylnikov, Francesca Costabile, Silvia Beghi, et al.
Translational research (2018) Vol. 202, pp. 35-51
Open Access | Times Cited: 121
Challenges and perspectives in the treatment of diabetes associated breast cancer
Samson Mathews Samuel, Elizabeth Varghese, Sharon Varghese, et al.
Cancer Treatment Reviews (2018) Vol. 70, pp. 98-111
Open Access | Times Cited: 105
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Józef Drzewoski, M Hanefeld
Pharmaceuticals (2021) Vol. 14, Iss. 2, pp. 122-122
Open Access | Times Cited: 102
Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations
Nikoletta Mili, Stavroula Α. Paschou, Dimitrios G. Goulis, et al.
Endocrine (2021) Vol. 74, Iss. 3, pp. 478-497
Closed Access | Times Cited: 97
Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling
Chi‐Cheng Lu, Jo‐Hua Chiang, Fuu‐Jen Tsai, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 92
Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer
Yi-Feng Hou, Shuang Cai, Shouyang Yu, et al.
Acta Biochimica et Biophysica Sinica (2021) Vol. 53, Iss. 3, pp. 333-341
Open Access | Times Cited: 86
The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives
Gerasimos Socrates Christodoulatos, Nikolaos Spyrou, Jona Kadillari, et al.
Current Obesity Reports (2019) Vol. 8, Iss. 4, pp. 413-433
Closed Access | Times Cited: 84
Occurrence, toxic effects and removal of metformin in the aquatic environments in the world: Recent trends and perspectives
Gustavo Axel Elizalde-Velázquez, Leobardo Manuel Gómez‐Oliván
The Science of The Total Environment (2019) Vol. 702, pp. 134924-134924
Closed Access | Times Cited: 84
Metformin and Breast Cancer: Where Are We Now?
Mónica Cejuela Solís, Begoña Martı́n-Castillo, Javier A. Menéndez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2705-2705
Open Access | Times Cited: 69
Page 1 - Next Page

Scroll to top